BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 11594902)

  • 21. Background hCG in non-pregnant individuals: need for more sensitive point-of-care and over-the-counter pregnancy tests.
    Cole LA; Ladner DG
    Clin Biochem; 2009 Feb; 42(3):168-75. PubMed ID: 18929550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of pregnancy around the first missed menstrual period by 2 hour haemagglutination test.
    Tamada T; Fukwai Z
    Acta Obstet Gynaecol Jpn; 1976 Jan; 23(1):23-6. PubMed ID: 1026032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Individual deviations in human chorionic gonadotropin concentrations during pregnancy.
    Cole LA
    Am J Obstet Gynecol; 2011 Apr; 204(4):349.e1-7. PubMed ID: 21324434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid hCG-specific radioimmunoassay for menstrual aspiration.
    Kosasa TS; Pion RJ; Hale RW; Goldstein DP; Taymor ML; Levesque LA; Kobara TY
    Obstet Gynecol; 1975 May; 45(5):566-8. PubMed ID: 1124174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis of pregnancy before the menstrual period is delayed. Interest of the determination of plasma chorionic gonadotropin (HCG) in fertility disorders].
    Chartier M; Barrat J; Michelon B; Soldat MC
    J Gynecol Obstet Biol Reprod (Paris); 1975; 4(7):927-37. PubMed ID: 1240884
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical abortion in patients with recurrent fetal loss.
    Oka C; Makino T; Itakura I; Hara T; Nozawa S; Iizuka R
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):239-40. PubMed ID: 1707432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Day-specific probabilities of conception in fertile cycles resulting in spontaneous pregnancies.
    Stirnemann JJ; Samson A; Bernard JP; Thalabard JC
    Hum Reprod; 2013 Apr; 28(4):1110-6. PubMed ID: 23340057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Menstrual cycle pattern and fertility: a prospective follow-up study of pregnancy and early embryonal loss in 295 couples who were planning their first pregnancy.
    Kolstad HA; Bonde JP; Hjøllund NH; Jensen TK; Henriksen TB; Ernst E; Giwercman A; Skakkebaek NE; Olsen J
    Fertil Steril; 1999 Mar; 71(3):490-6. PubMed ID: 10065787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using a simulation model to assess risk of false negative point-of-care urinary human chorionic gonadotropin device results due to high-dose hook interference.
    Milhorn D; Korpi-Steiner N
    Clin Biochem; 2015 Feb; 48(3):99-104. PubMed ID: 25448030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jointly modelling longitudinally measured urinary human chorionic gonadotrophin and early pregnancy outcomes.
    Ashra NB; Marriott L; Johnson S; Abrams KR; Crowther MJ
    Sci Rep; 2020 Mar; 10(1):4589. PubMed ID: 32165717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the Home Ovarian Monitor in pregnancy avoidance.
    Brown JB; Holmes J; Barker G
    Am J Obstet Gynecol; 1991 Dec; 165(6 Pt 2):2008-11. PubMed ID: 1755460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of early pregnancy loss.
    Ellish NJ; Saboda K; O'Connor J; Nasca PC; Stanek EJ; Boyle C
    Hum Reprod; 1996 Feb; 11(2):406-12. PubMed ID: 8671233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prospective assessment of early fetal loss using an immunoenzymometric screening assay for detection of urinary human chorionic gonadotropin.
    Taylor CA; Overstreet JW; Samuels SJ; Boyers SP; Canfield RE; O'Connor JF; Hanson FW; Lasley BL
    Fertil Steril; 1992 Jun; 57(6):1220-4. PubMed ID: 1601143
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neocept: a simple, sensitive urine test of early pregnancy in women undergoing ovulation induction.
    Wang CF; Gemzell C
    J Reprod Med; 1982 Apr; 27(4):193-5. PubMed ID: 6808132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of relaxin secretion in nonpregnant women by human chorionic gonadotropin.
    Quagliarello J; Goldsmith L; Steinetz B; Lustig DS; Weiss G
    J Clin Endocrinol Metab; 1980 Jul; 51(1):74-7. PubMed ID: 7380995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A commercial pregnancy test modified for field studies of fetal loss.
    Holman DJ; Rasheed FN; Stroud CM; Brindle E; O'Connor KA; Campbell KL
    Clin Chim Acta; 1998 Mar; 271(1):25-44. PubMed ID: 9564555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantification of urinary chorionic gonadotropin in spontaneous abortion of pre-clinically recognized pregnancy: method development and analytical validation.
    Reis MF; Aniceto P; Aguiar P; Simão F; Segurado S
    Int J Hyg Environ Health; 2007 May; 210(3-4):419-27. PubMed ID: 17336148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary hCG patterns during the week following implantation.
    Nepomnaschy PA; Weinberg CR; Wilcox AJ; Baird DD
    Hum Reprod; 2008 Feb; 23(2):271-7. PubMed ID: 18083748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Appearance of hCG in pregnancy plasma following the initiation of implantation of the blastocyst.
    Catt KJ; Dufau ML; Vaitukaitis JL
    J Clin Endocrinol Metab; 1975 Mar; 40(3):537-40. PubMed ID: 1117063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.